pI: 8.471 |
Length (AA): 507 |
MW (Da): 58492 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 1
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_136757)
Species | Accession | Gene Product |
---|---|---|
Drosophila melanogaster | Dmel_CG10663 | CG10663 gene product from transcript CG10663-RD |
Echinococcus granulosus | EgrG_000184900 | glycoprotein Antigen 5 |
Echinococcus granulosus | EgrG_000085400 | Mastin |
Echinococcus granulosus | EgrG_000165600 | enteropeptidase |
Echinococcus multilocularis | EmuJ_000184900 | glycoprotein Antigen 5 |
Echinococcus multilocularis | EmuJ_000165600 | enteropeptidase |
Echinococcus multilocularis | EmuJ_000085400 | Mastin |
Homo sapiens | ENSG00000115718 | protein C (inactivator of coagulation factors Va and VIIIa) |
Mus musculus | ENSMUSG00000024386 | protein C |
Schistosoma japonicum | Sjp_0301550 | ko:K01346 pancreatic elastase II [EC3.4.21.71], putative |
Schistosoma mansoni | Smp_002150 | subfamily S1A unassigned peptidase (S01 family) |
Schmidtea mediterranea | mk4.021987.00 | Subfamily S1A unassigned peptidase |
Schmidtea mediterranea | mk4.004023.01 | Subfamily S1A unassigned peptidase |
Schmidtea mediterranea | mk4.000391.11 | |
Schmidtea mediterranea | mk4.000391.03 | |
Schmidtea mediterranea | mk4.000391.10 | |
Schmidtea mediterranea | mk4.005110.02 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | protein C (inactivator of coagulation factors Va and VIIIa) | Compounds | References |
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Bos taurus | Beta-chymotrypsin | 245 aa | 25.2% | 314 aa | Compounds | References |
Rattus norvegicus | Trypsin II | 246 aa | 27.9% | 305 aa | Compounds | References |
Oryctolagus cuniculus | Thrombin | 235 aa | 26.3% | 281 aa | Compounds | References |
Bos taurus | Trypsin II | 247 aa | 24.8% | 303 aa | Compounds | References |
Canis lupus familiaris | Tryptase | 275 aa | 29.0% | 310 aa | Compounds | References |
Canis lupus familiaris | Coagulation factor X | 159 aa | 23.3% | 219 aa | Compounds | References |
Sus scrofa | Elastase 1 | 266 aa | 24.8% | 310 aa | Compounds | References |
Rattus norvegicus | Anionic trypsin-1 | 246 aa | 27.7% | 311 aa | Compounds | References |
Sus scrofa | Pancreatic elastase | 269 aa | 28.1% | 306 aa | Compounds | References |
Bos taurus | Trypsin I | 246 aa | 23.9% | 305 aa | Compounds | References |
Rattus norvegicus | Elastase 2A | 271 aa | 28.4% | 313 aa | Compounds | References |
Sus scrofa | Elastase 2A | 269 aa | 28.1% | 306 aa | Compounds | References |
Rattus norvegicus | Tryptase alpha/beta-1 | 273 aa | 32.7% | 309 aa | Compounds | References |
Sus scrofa | Trypsin | 231 aa | 24.1% | 303 aa | Compounds | References |
Sus scrofa | Glandular kallikrein | 246 aa | 26.8% | 314 aa | Compounds | References |
Bos taurus | Alpha-chymotrypsin | 245 aa | 24.5% | 314 aa | Compounds | References |
Rattus norvegicus | Mast cell protease 3 | 247 aa | 24.6% | 301 aa | Compounds | References |